NCT01263015 · Interventional trial
A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)
Overall registry status Completed
Phase 3
Conditions Infection, Human Immunodeficiency Virus I
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory